Search Your Trial
View Clinical Trials
- C08.381.840.500.475
- C08.381.840.500.737
- C10.114.375.500
- C10.228.140.140.254
- C11.768.740
- C14
- C14.280.067.198
- C14280647250
- C14907933
- C14907933125
- C1 Esterase Inhibitor Deficiency
- C1 Inhibitor Deficiency
- C3G
- C3 Glomerulonephritis
- C3 Glomerulopathy
- C3 Glomerulopathy (C3G)
- C3PI Study Testing Group
- C4 Deficiency
- C535854
- C9orf72
- C9orf72 Amyotrophic Lateral Sclerosis (ALS)
- C9ORF72 Amyotrophic Lateral Sclerosis (ALS)
- CA 125 Antigen
- CA 19.9
- CA2 and CA3 Residents Doing a Two Month Rotation in
- Cabazitaxel
- Cabergoline Adverse Reaction
- CABG
- CABG Graft Integrity
- CABG-Induced Oxidative Stress
- CABG in Low EF
- CABG-Patients
- CABGs
- CABG Surgery
- CABG Surgery, Cold Blood Cardioplegia, Coagulation Profile and Platelet Function
- Cachexia
- Cachexia; Cancer
- Cachexia; Cancer; Sarcopenia
- CACNA1C
- C. Acnes
- CAD
- Cadasil
- CADASIL
- Cadaver
- Cadaveric Donor Renal Transplantation
- CAD - Coronary Artery Disease
- Cadmium Body Burden
- CAD Patients
- CAD Test; Children's Vision; Colour Assessment; Colour Vision; Turkey
- CAEBV